Comparing qualitative and quantitative spectroscopic techniques for the detection of the effect of direct iron loading of mammalian cell cultures

Methods in Cell Science

Volumn 23, Issue 4, 2001, Pages 175-184

  Traore, Hafsatou Ndama ^a   Meyer, Debra ^a  

^a UNIVERSITY OF JOHANNESBURG   (South Africa)

Author keywords

Fe overload; Flow cytometry; ICP AES; Viability dyes

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANILIDE; DEFEROXAMINE; DYE; EDETATE IRON; FERROUS SULFATE; IRON; IRON CHELATING AGENT; METAL; TRYPTOPHAN; COLORING AGENT; DIAGNOSTIC AGENT; FERRIC ION; FERRIC SULFATE;

APOPTOSIS; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CELL ASSAY; CELL CULTURE; CELL LEVEL; CELL STRAIN U937; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERMETHOD COMPARISON; IRON CHELATION; IRON OVERLOAD; IRON TRANSPORT; LEUKOCYTE; MAMMAL CELL; MONONUCLEAR CELL; NECROSIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RELIABILITY; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; CELL DEATH; CELL SURVIVAL; CULTURE TECHNIQUE; CYTOLOGY; IMMUNE SYSTEM; INSTRUMENTATION; IRON METABOLISM DISORDER; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

CELL CULTURE; CELL DEATH; CELL SURVIVAL; COMPARATIVE STUDY; DEFEROXAMINE; DYES; FERRIC COMPOUNDS; FLOW CYTOMETRY; HUMAN; IMMUNE SYSTEM; IRON; IRON CHELATING AGENTS; IRON METABOLISM DISORDERS; LEUKOCYTES; SPECTRUM ANALYSIS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; CELL CULTURE TECHNIQUES; COLORING AGENTS; HUMANS;

MAMMALIA;

EID: 0035545305     PISSN: 13815741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016313221027     Document Type: Article

References (24)

1. In vitro viability, mitogenicity and clonogenic capacity of periodontal ligament cells after storage in four media at room temperature
2. Differential regulation and expression of stress proteins and ferritin in human monocytes
3. Chromium speciation by anion-exchange high performance liquid chromatography with both inductively coupled plasma atomic emission spectroscopic and inductively coupled plasma mass spectrometic detection
4. Iron deprivation-induced apoptosis in HL-60 cells
5. A semiautomated multparameter approach for anti-HIV drug screening
6. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates
7. Iron augments macrophage-mediated killing of Brucella abortus alone and in conjunction with interferon-gamma
8. Modulation of cell surface iron transferrin receptors by cellular density and state of activation
9. Deferoxamine: A reversible S-phase inhibitor of human lymphocyte proliferation
10. Tuberculosis and iron overload in Africa: A review
11. Annexin V staining during reperfusion detects cardiomyocytes with unique properties
12. Iron and infection
13. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
14. Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine
15. Nitric Oxide-mediated induction of Ferritin synthesis in J774 macrophages by inflammatory cytokines: Role of selective iron regulatory protein-2 downregulation
16. Effects of iron and desferrioxamine on infections with Yersinia enterocolitica
17. Iron regulates microglial cell-mediated secretory and effector functions
18. Determination of halogens, with special reference to iodine, in geological and biological samples using pyrohydrolysis for preparation and inductively coupled plasma mass spectrometry and ion chromatography for measurement
19. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
20. Polychlorinaed biphenyl mixtures (Aroclors) inhibit LPS-induced murine splenocyte proliferation in vitro
21. Application and evaluation of the Alamar Blue assay for cell growth and survival of fibroblasts
22. Effects of iron overload on the immune system
23. Iron loading and disease surveillance
24. Cell proliferation and viability